Pharmaceutical Technology

MAY 10, 2023

Microparticles can be present as a contamination of products such as pharmaceuticals and electronics, or as an air pollutant. Within the pharmaceutical industry, it is critical to measure particle size as it influences surface area and porosity, impacting a drug’s bioavailability, effectiveness, and shelf life.

Contamination 130

Contamination Filler Bioavailability Production 130

Pharmaceutical Technology

APRIL 12, 2023

The ingredients used in these drugs are high potency, even at small doses, and pose a risk to both human health and cross-contamination with other drugs in a manufacturing environment. This prevents contamination of the elements by the sampled powder.

Manufacturing 130

Manufacturing Production Containment Contamination 130

Pharmaceutical Technology

FEBRUARY 3, 2023

Additionally, OSD manufacturing approaches are well developed, with processes that ensure a repeatable distribution of ingredients, uniformity in dissolution, and bioavailability, which verify that the drug product is safe and effective. Please check your email to download the Webinar.

Contamination 130

Contamination Manufacturing Containment Production 130

Pharmaceutical Technology

JUNE 14, 2023

Containment challenges and opportunities High containment facilities guard against exposure to extremely potent products and cross-contamination. Similarly, more modern equipment for micronization, such as fluid energy and jet mills, comes with limitations such as potential contamination and excess wear on machinery.

Containment 130

Containment Manufacturing Contract Manufacturing Bioavailability 130